GLP-1 drugs like Ozempic may increase hair loss risk in men

A new study suggests that increased GLP-1 receptor activity may be associated with higher risk of androgenetic alopecia in men, particularly those genetically predisposed to hair loss. Results apply to drugs such as Ozempic and Wegovy. The study is observational and indicates a need for further research.